On the public citation graph
Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III Studies
0 signed · 541 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/(sici)1097-0142(19970415)79:8<1516::aid-cncr11>3.0.co;2-0openalex-snapshot
Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma
inferredcites →https://doi.org/10.1002/1097-0142(19811015)48:8<1705::aid-cncr2820480803>3.0.co;2-4openalex-snapshot
Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. The gastrointestinal tumor study group
inferredcites →https://doi.org/10.1002/1097-0142(19871101)60:9<2284::aid-cncr2820600930>3.0.co;2-vopenalex-snapshot
Cancer of the pancreas: 50 years of surgery
inferredcites →https://doi.org/10.1002/jso.10159openalex-snapshot
Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer
inferredcites →https://doi.org/10.1016/j.ijrobp.2004.12.074openalex-snapshot
A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282
inferredcites →https://doi.org/10.1016/j.ijrobp.2005.04.030openalex-snapshot
Capecitabine and radiation therapy preceded and followed by combination chemotherapy in advanced pancreatic cancer
inferredcites →https://doi.org/10.1016/s0360-3016(01)01708-4openalex-snapshot
Radiotherapy and continuous infusion 5-fluorouracil in patients with nonresectable pancreatic carcinoma
inferredcites →https://doi.org/10.1016/s0360-3016(99)00478-2openalex-snapshot
Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study
inferredcites →https://doi.org/10.1016/s0399-8320(04)95042-7openalex-snapshot
Phase II study of leucovorin, 5-fluorouracil and gemcitabine for locally advanced and metastatic pancreatic cancer (FOLFUGEM 2)
inferredcites →https://doi.org/10.1023/a:1011139808426openalex-snapshot
Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM)
inferredcites →https://doi.org/10.1054/bjoc.1999.0884openalex-snapshot
Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin
inferredcites →https://doi.org/10.1093/annonc/mdg109openalex-snapshot
Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic Cancer
inferredcites →https://doi.org/10.1093/jnci/80.10.751openalex-snapshot
Treatment of Locally Unresectable Carcinoma of the Pancreas: Comparison of Combined-Modality Therapy (Chemotheraphy Plus Radiotherapy) to Chemotheraphy Alone1
inferredcites →https://doi.org/10.1093/oxfordjournals.annonc.a010600openalex-snapshot
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer
inferredcites →https://doi.org/10.1097/01.coc.0000159559.42311.c5openalex-snapshot
Phase II Trial of Induction Gemcitabine/CPT-11 Followed by a Twice-Weekly Infusion of Gemcitabine and Concurrent External Beam Radiation for the Treatment of Locally Advanced Pancreatic Cancer
inferredcites →https://doi.org/10.1200/jco.1985.3.3.373openalex-snapshot
Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study.
inferredcites →https://doi.org/10.1200/jco.1995.13.1.227openalex-snapshot
Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group Trial.
inferredcites →https://doi.org/10.1200/jco.1997.15.6.2403openalex-snapshot
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
inferredcites →https://doi.org/10.1200/jco.20.6.1512openalex-snapshot
Gemcitabine Combined With Oxaliplatin in Advanced Pancreatic Adenocarcinoma: Final Results of a GERCOR Multicenter Phase II Study
inferredcites →https://doi.org/10.1200/jco.2001.19.10.2679openalex-snapshot
Definitive Results of a Phase II Trial of Cisplatin, Epirubicin, Continuous-Infusion Fluorouracil, and Gemcitabine in Stage IV Pancreatic Adenocarcinoma
inferredcites →https://doi.org/10.1200/jco.2003.03.022openalex-snapshot
Phase II Study of Gemcitabine, Cisplatin, and Infusional Fluorouracil in Advanced Pancreatic Cancer
inferredcites →https://doi.org/10.1200/jco.2004.10.112openalex-snapshot
Phase III Trial of Gemcitabine Plus Tipifarnib Compared With Gemcitabine Plus Placebo in Advanced Pancreatic Cancer
inferredcites →https://doi.org/10.1200/jco.2004.12.082openalex-snapshot
Irinotecan Plus Gemcitabine Results in No Survival Advantage Compared With Gemcitabine Monotherapy in Patients With Locally Advanced or Metastatic Pancreatic Cancer Despite Increased Tumor Response Rate
inferredcites →https://doi.org/10.1200/jco.2004.22.14_suppl.3776openalex-snapshot
Laparoscopic radiofrequency ablation and systemic chemotherapy for colorectal liver metastases
inferredcites →https://doi.org/10.1200/jco.2005.06.023openalex-snapshot
Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III Trial
inferredcites →https://doi.org/10.1200/jco.2006.24.18_suppl.4008openalex-snapshot
Phase III trial comparing initial chemoradiotherapy (intermittent cisplatin and infusional 5-FU) followed by gemcitabine vs. gemcitabine alone in patients with locally advanced non metastatic pancreatic cancer: A FFCD-SFRO study
inferredcites →https://doi.org/10.1200/jco.2006.24.18_suppl.4036openalex-snapshot
Neoadjuvant chemotherapy improves outcomes of chemoradiation therapy for locally advanced pancreatic cancer
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4706360openalex-extracted
Standard or High Dose Chemoradiotherapy, with or Without the Protease Inhibitor Nelfinavir, for the Treatment of Locally Advanced Pancreatic Cancer: Efficacy, Safety and Health-Related Quality of Life Outcomes from the Multi-Centre Two Stage Phase 1/Randomised Phase 2 SCALOP-2 Study
inferred← citeshttps://doi.org/10.1001/jama.2016.4324openalex-snapshot
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib
inferred← citeshttps://doi.org/10.1002/9781118512074.ch146openalex-snapshot
Endoscopic Ultrasonography
inferred← citeshttps://doi.org/10.1002/9781118512074.ch87openalex-snapshot
Adenocarcinoma of the Pancreas
inferred← citeshttps://doi.org/10.1002/9781118592168.ch6openalex-snapshot
Adenocarcinoma of the Pancreas
inferred← citeshttps://doi.org/10.1002/9781119000822.hfcm094openalex-snapshot
Neoplasms of the Exocrine Pancreas
inferred← citeshttps://doi.org/10.1002/9781119000822.hfcm094.pub2openalex-snapshot
Neoplasms of the Exocrine Pancreas
inferred← citeshttps://doi.org/10.1002/bab.1657openalex-snapshot
Gemcitabine induces apoptosis and autophagy via the AMPK/mTOR signaling pathway in pancreatic cancer cells
inferred← citeshttps://doi.org/10.1002/bjs.8789openalex-snapshot
Combined modality treatment for patients with locally advanced pancreatic adenocarcinoma
inferred← citeshttps://doi.org/10.1002/bjs.9444openalex-snapshot
Para-aortic lymph node sampling in pancreatic head adenocarcinoma
inferred← citeshttps://doi.org/10.1002/cam4.1553openalex-snapshot
Prospective analysis of different combined regimens of stereotactic body radiation therapy and chemotherapy for locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1002/cam4.2326openalex-snapshot
Duration of chemotherapy prior to chemoradiation affects survival outcomes for resected stage I‐II or unresected stage III pancreatic cancer
inferred← citeshttps://doi.org/10.1002/cam4.3119openalex-snapshot
Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation
inferred← citeshttps://doi.org/10.1002/cncr.25282openalex-snapshot
Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1002/cncr.25742openalex-snapshot
A phase 2 trial of gemcitabine, 5‐fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma
inferred← citeshttps://doi.org/10.1002/cncr.26633openalex-snapshot
Long‐term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1002/cncr.27736openalex-snapshot
Induction gemcitabine and oxaliplatin therapy followed by a twice‐weekly infusion of gemcitabine and concurrent external‐beam radiation for neoadjuvant treatment of locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1002/cncr.29161openalex-snapshot
Phase 2 multi‐institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma
inferred← citeshttps://doi.org/10.1002/cncr.29652openalex-snapshot
Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base
inferred← citeshttps://doi.org/10.1002/cncr.30199openalex-snapshot
A comparative analysis of survival outcomes between pancreatectomy and chemotherapy for elderly patients with adenocarcinoma of the pancreas
inferred← citeshttps://doi.org/10.1002/cncr.30780openalex-snapshot
Multiagent induction chemotherapy followed by chemoradiation is associated with improved survival in locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1002/jhbp.408openalex-snapshot
Risk factors for latent distant organ metastasis detected by staging laparoscopy in patients with radiologically defined locally advanced pancreatic ductal adenocarcinoma
inferred← citeshttps://doi.org/10.1002/jso.23137openalex-snapshot
Role of radiation therapy in the management of pancreatic cancer
inferred← citeshttps://doi.org/10.1002/jso.23230openalex-snapshot
Adjuvant therapy for pancreas adenocarcinoma
inferred← citeshttps://doi.org/10.1002/jso.23921openalex-snapshot
Neoadjuvant modified FOLFIRINOX and chemoradiation therapy for locally advanced pancreatic cancer improves resectability
inferred← citeshttps://doi.org/10.1002/jso.24375openalex-snapshot
Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy?
inferred← citeshttps://doi.org/10.1002/jso.24640openalex-snapshot
Multi‐disciplinary management of locally advanced pancreatic cancer with irreversible electroporation
inferred← citeshttps://doi.org/10.1002/jso.25004openalex-snapshot
Perioperative outcomes and survival following neoadjuvant stereotactic body radiation therapy (SBRT) versus intensity‐modulated radiation therapy (IMRT) in pancreatic adenocarcinoma
inferred← citeshttps://doi.org/10.1002/jso.26202openalex-snapshot
Utilization of chemoradiation therapy provides strongest protective effect for avoidance of postoperative pancreatic fistula following pancreaticoduodenectomy: A NSQIP analysis
inferred← citeshttps://doi.org/10.1002/jso.26415openalex-snapshot
Multidisciplinary management of locally advanced pancreatic adenocarcinoma: Biology is King
inferred← citeshttps://doi.org/10.1002/jso.27085openalex-snapshot
Long‐term follow‐up experience with adjuvant therapy after irreversible electroporation of locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1002/jso.27851openalex-snapshot
Trends in the Care of Locally Advanced Pancreatic Cancer in the Modern Era of Chemotherapy
inferred← citeshttps://doi.org/10.1002/pro6.1080openalex-snapshot
Changing paradigm of radiation therapy for the treatment of pancreatic cancer
inferred← citeshttps://doi.org/10.1002/pro6.1156openalex-snapshot
Comparing concurrent chemoradiotherapy, 125I seed implantation combined with chemotherapy, and chemotherapy alone efficacy in treating unresectable locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1007/174_2010_2openalex-snapshot
The Locally Advanced Nonmetastatic Cancer
inferred← citeshttps://doi.org/10.1007/978-0-387-77498-5_26openalex-snapshot
Clinical Decision Making in Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-0-387-77498-5_37openalex-snapshot
Chemotherapy for Advanced Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-0-85729-597-2_10openalex-snapshot
Stereotactic Body Radiotherapy (SBRT) for Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-1-4020-8900-8_22openalex-snapshot
Unresectable Locally Advanced Pancreatic Cancer: Concurrent Chemotherapy
inferred← citeshttps://doi.org/10.1007/978-1-4939-1423-4_13openalex-snapshot
Pancreatic Adenocarcinoma
inferred← citeshttps://doi.org/10.1007/978-1-4939-6631-8_26-2openalex-snapshot
Clinical Decision-Making in Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-1-4939-6631-8_37-2openalex-snapshot
Chemotherapy for Advanced Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-1-4939-6631-8_37-3openalex-snapshot
Chemotherapy for Advanced Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-1-4939-6631-8_88-1openalex-snapshot
Role of Radiotherapy in Locally Advanced Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-1-4939-7193-0_37openalex-snapshot
Chemotherapy for Advanced Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-1-4939-7193-0_88openalex-snapshot
Role of Radiotherapy in Locally Advanced Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-2-8178-0021-9_26openalex-snapshot
Chimiothérapie et radiothérapie des cancers pancréatiques
inferred← citeshttps://doi.org/10.1007/978-3-030-48363-0_21openalex-snapshot
Adenocarcinoma of the Pancreas
inferred← citeshttps://doi.org/10.1007/978-3-031-05724-3_9openalex-snapshot
Management of Locally Advanced/Metastatic Disease: Medical Oncology
inferred← citeshttps://doi.org/10.1007/978-3-031-38623-7_3openalex-snapshot
Radiation Therapy for Pancreatic Cancer: Current and Evolving Paradigms
inferred← citeshttps://doi.org/10.1007/978-3-319-22780-1_13openalex-snapshot
The Role and Techniques of Vascular Resection
inferred← citeshttps://doi.org/10.1007/978-3-319-22780-1_18openalex-snapshot
The Role of Irreversible Electroporation and Other Ablative Techniques in Patients with Borderline Resectable Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-3-319-22780-1_8openalex-snapshot
Stereotactic Body Radiation Therapy as an Emerging Option for Localized Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-3-319-26276-5_19openalex-snapshot
Adenocarcinoma of the Pancreas
inferred← citeshttps://doi.org/10.1007/978-3-319-26779-1_111-1openalex-snapshot
Irreversible Electroporation Techniques in the Treatment of Locally Advanced Liver and Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-3-319-32886-7_111openalex-snapshot
Irreversible Electroporation Techniques in the Treatment of Locally Advanced Liver and Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-3-319-42358-6_3openalex-snapshot
Radiofrequency Ablation of Pancreatic Mass
inferred← citeshttps://doi.org/10.1007/978-3-319-64900-9_8openalex-snapshot
Resectable and Borderline Resectable Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-3-319-98944-0_11openalex-snapshot
Role of Radiation for Locally Advanced Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-3-642-04935-4_44openalex-snapshot
Strahlentherapie in der Behandlung des Pankreaskarzinoms
inferred← citeshttps://doi.org/10.1007/978-3-642-13306-0_8openalex-snapshot
Unresectable Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-3-642-37964-2_72openalex-snapshot
Ist Radiochemotherapie beim Pankreaskarzinom effektiv?
inferred← citeshttps://doi.org/10.1007/978-3-642-37964-2_75openalex-snapshot
Was bringt eine neoadjuvante Chemotherapie beim Pankreaskarzinom?
inferred← citeshttps://doi.org/10.1007/978-3-642-40558-7_19openalex-snapshot
External Beam Radiation Therapy: 3D-Conformal, Intensity-Modulated, and Proton Beam
inferred← citeshttps://doi.org/10.1007/978-3-662-47181-4_37openalex-snapshot
Chemotherapy in the Management of Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-3-662-47181-4_41openalex-snapshot
Emerging New Treatment Modalities: Irreversible Electroporation
inferred← citeshttps://doi.org/10.1007/978-3-662-48727-3_26openalex-snapshot
Pankreaskarzinom beim alten und geriatrischen Patienten
inferred← citeshttps://doi.org/10.1007/978-3-662-49083-9_26-1openalex-snapshot
Pankreaskarzinom beim alten und geriatrischen Patienten
inferred← citeshttps://doi.org/10.1007/978-88-470-0856-4_37openalex-snapshot
Chemotherapy and Radiotherapy in Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-981-287-817-5_7openalex-snapshot
Optimal Irreversible Electroporation Techniques in the Treatment of Locally Advanced Liver and Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/bf02961807openalex-snapshot
Place De La Radiothérapie Dans Le Traitement Du Cancer Du Pancréas Localement Avancé
inferred← citeshttps://doi.org/10.1007/s00066-011-2226-6openalex-snapshot
Regional hyperthermia combined with chemoradiotherapy in primary or recurrent locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s00066-016-1053-1openalex-snapshot
Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s00066-016-1058-9openalex-snapshot
Die LAP07-Studienergebnisse sollten nicht als Aus der Radiochemotherapie für das Pankreaskarzinom missverstanden werden
inferred← citeshttps://doi.org/10.1007/s00066-017-1227-5openalex-snapshot
Essential role of radiation therapy for the treatment of pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s00066-018-1281-7openalex-snapshot
Nonmetastatic pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s00117-008-1753-3openalex-snapshot
Internistisch-onkologische Aspekte bei der Behandlung des Pankreaskarzinoms
inferred← citeshttps://doi.org/10.1007/s00117-008-1758-yopenalex-snapshot
Die Rolle der Strahlentherapie bei der Behandlung des Pankreaskarzinoms aus der Sicht des Radioonkologen
inferred← citeshttps://doi.org/10.1007/s00262-020-02701-wopenalex-snapshot
Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide
inferred← citeshttps://doi.org/10.1007/s00270-013-0724-xopenalex-snapshot
Minimally Invasive Ablation Treatment for Locally Advanced Pancreatic Adenocarcinoma
inferred← citeshttps://doi.org/10.1007/s00280-008-0836-1openalex-snapshot
Phase II trial of S-1 and concurrent radiotherapy in patients with locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s00280-009-0980-2openalex-snapshot
Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s00280-009-0995-8openalex-snapshot
Outcome of upfront combination chemotherapy followed by chemoradiation for locally advanced pancreatic adenocarcinoma
inferred← citeshttps://doi.org/10.1007/s00280-009-1193-4openalex-snapshot
A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s00280-012-1918-7openalex-snapshot
Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s00280-017-3350-5openalex-snapshot
Phase II study of induction gemcitabine and S-1 followed by chemoradiotherapy and systemic chemotherapy using S-1 for locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s00432-019-03066-zopenalex-snapshot
Clinical outcomes and prognostic factors of stereotactic body radiation therapy combined with gemcitabine plus capecitabine for locally advanced unresectable pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s00432-020-03411-7openalex-snapshot
Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients
inferred← citeshttps://doi.org/10.1007/s00464-015-4216-8openalex-snapshot
Biliary stenting is not a prerequisite to endoscopic placement of duodenal covered self-expandable metal stents
inferred← citeshttps://doi.org/10.1007/s00464-024-11450-1openalex-snapshot
Radiofrequency ablation (RFA) in unresectable pancreatic adenocarcinoma: meta-analysis & systematic review
inferred← citeshttps://doi.org/10.1007/s00740-020-00326-4openalex-snapshot
Rolle der Radiotherapie beim Pankreaskarzinom
inferred← citeshttps://doi.org/10.1007/s00761-010-1845-3openalex-snapshot
Stellenwert der Strahlentherapie im Therapiekonzept des Pankreaskarzinoms
inferred← citeshttps://doi.org/10.1007/s00761-016-0088-3openalex-snapshot
Die randomisierte LAP07-Studie
inferred← citeshttps://doi.org/10.1007/s00761-019-0546-9openalex-snapshot
Rolle der Radiotherapie beim Pankreaskarzinom
inferred← citeshttps://doi.org/10.1007/s10147-007-0739-xopenalex-snapshot
Current status of chemoradiotherapy for locally advanced pancreatic cancer in Japan
inferred← citeshttps://doi.org/10.1007/s10147-007-0763-xopenalex-snapshot
Chemoradiotherapy for unresectable pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s10147-017-1129-7openalex-snapshot
Change in carbohydrate antigen 19-9 level as a prognostic marker of overall survival in locally advanced pancreatic cancer treated with concurrent chemoradiotherapy
inferred← citeshttps://doi.org/10.1007/s10269-015-2561-9openalex-snapshot
Place de la radiothérapie (et chimioradiothérapie) dans les cancers localement avancés ou borderline. Quelles perspectives ?
inferred← citeshttps://doi.org/10.1007/s10353-019-0577-xopenalex-snapshot
Integrating radiation oncology into the management of pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s10620-014-3170-yopenalex-snapshot
Increased Rates of Duodenal Obstruction in Pancreatic Cancer Patients Receiving Modern Medical Management
inferred← citeshttps://doi.org/10.1007/s10620-021-07262-1openalex-snapshot
Silencing GS Homeobox 2 Alleviates Gemcitabine Resistance in Pancreatic Cancer Cells by Activating SHH/GLI1 Signaling Pathway
inferred← citeshttps://doi.org/10.1007/s11596-016-1567-xopenalex-snapshot
Implantation of radioactive 125I seeds improves the prognosis of locally advanced pancreatic cancer patients: A retrospective study
inferred← citeshttps://doi.org/10.1007/s11605-010-1323-7openalex-snapshot
Image-Guided Stereotactic Radiosurgery for Locally Advanced Pancreatic Adenocarcinoma Results of First 85 Patients
inferred← citeshttps://doi.org/10.1007/s11605-017-3595-7openalex-snapshot
Common Hepatic Artery Abutment or Encasement Is an Adverse Prognostic Factor in Patients with Borderline and Unresectable Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/s11654-013-0072-yopenalex-snapshot
Lokale Therapieverfahren beim Pankreaskarzinom
inferred← citeshttps://doi.org/10.1007/s11670-011-0194-0openalex-snapshot
Combination of recombinant adenovirus-p53 with radiochemotherapy in unresectable pancreatic carcinoma
inferred← citeshttps://doi.org/10.1007/s11845-018-1755-8openalex-snapshot
The emerging role of stereotactic radiotherapy in gastrointestinal malignancies: a review of the literature and analysis from the Irish perspective
inferred← citeshttps://doi.org/10.1007/s11912-012-0290-4openalex-snapshot
The Role of the FOLFIRINOX Regimen for Advanced Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/s11912-012-0291-3openalex-snapshot
Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer: An Emerging Paradigm?
inferred← citeshttps://doi.org/10.1007/s11912-014-0388-yopenalex-snapshot
Management Options in Locally Advanced Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/s12029-012-9419-9openalex-snapshot
Identification of Distinct Phenotypes of Locally Advanced Pancreatic Adenocarcinoma
inferred← citeshttps://doi.org/10.1007/s12094-012-0962-4openalex-snapshot
Multidisciplinary management of locally advanced–borderline resectable adenocarcinoma of the head of the pancreas
inferred← citeshttps://doi.org/10.1007/s12094-012-0998-5openalex-snapshot
Beam angle selection for intensity-modulated radiotherapy (IMRT) treatment of unresectable pancreatic cancer: are noncoplanar beam angles necessary?
inferred← citeshttps://doi.org/10.1007/s12094-014-1177-7openalex-snapshot
TTD consensus document on the diagnosis and management of exocrine pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s12094-017-1679-1openalex-snapshot
Management of unresectable, locally advanced pancreatic adenocarcinoma
inferred← citeshttps://doi.org/10.1007/s12094-021-02671-0openalex-snapshot
The role of radiotherapy for pancreatic malignancies: a population-based analysis of the SEER database
inferred← citeshttps://doi.org/10.1007/s12254-008-0007-4openalex-snapshot
Future perspectives in the treatment of pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s12254-011-0303-2openalex-snapshot
The role of radiochemotherapy in the multimodal treatment of pancreatic ductal adenocarcinoma: Standard procedure or individual decision?
inferred← citeshttps://doi.org/10.1007/s12328-010-0157-xopenalex-snapshot
Three cases of locally advanced pancreatic cancer successfully treated with chemoradiation and chemotherapy
inferred← citeshttps://doi.org/10.1007/s13193-014-0371-yopenalex-snapshot
Advances in Chemotherapy for Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/s13246-024-01447-4openalex-snapshot
Dosimetric characteristics of self-expandable metallic and plastic stents for transpapillary biliary decompression in external beam radiotherapy
inferred← citeshttps://doi.org/10.1007/s13566-012-0027-xopenalex-snapshot
Stereotactic body radiation therapy (SBRT) for pancreatic and non-hepatobiliary gastrointestinal (GI) malignancies
inferred← citeshttps://doi.org/10.1007/s15004-015-0712-1openalex-snapshot
Nur in seltenen Fällen besteht die Chance auf Heilung
inferred← citeshttps://doi.org/10.1007/s15035-008-0127-7openalex-snapshot
Aktuelle radioonkologische Konzepte in der Behandlung des Adenokarzinoms des Pankreas
inferred← citeshttps://doi.org/10.1016/b978-0-12-408103-1.00003-0openalex-snapshot
Multimodal Therapies for Pancreatic Cancer
inferred← citeshttps://doi.org/10.1016/b978-0-323-47674-4.00078-5openalex-snapshot
Carcinoma of the Pancreas
inferred← citeshttps://doi.org/10.1016/b978-0-323-91689-9.00016-9openalex-snapshot
Pancreatic cancers
inferred← citeshttps://doi.org/10.1016/b978-1-4160-5897-7.00039-1openalex-snapshot
Cancer of the Pancreas
inferred← citeshttps://doi.org/10.1016/b978-1-4557-2865-7.00081-3openalex-snapshot
Carcinoma of the Pancreas
inferred← citeshttps://doi.org/10.1016/b978-3-437-21212-3.10048-7openalex-snapshot
Literaturhinweise und Internetadressen
inferred← citeshttps://doi.org/10.1016/j.adro.2024.101577openalex-snapshot
Clinical Outcomes of Proton Beam Therapy for Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Retrospective Study
inferred← citeshttps://doi.org/10.1016/j.adro.2025.101742openalex-snapshot
Long-Term Survival Following Chemoradiation in Locoregional Recurrent Germline ATM Mutated Pancreatic Ductal Adenocarcinoma
inferred← citeshttps://doi.org/10.1016/j.amjsurg.2007.12.017openalex-snapshot
Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma
inferred← citeshttps://doi.org/10.1016/j.amjsurg.2016.04.008openalex-snapshot
Localized pancreatic cancer with positive peritoneal cytology as a sole manifestation of metastatic disease: a single-institution experience
inferred← citeshttps://doi.org/10.1016/j.bbcan.2017.02.003openalex-snapshot
Biological determinants of radioresistance and their remediation in pancreatic cancer
inferred← citeshttps://doi.org/10.1016/j.bmcl.2011.08.005openalex-snapshot
Pancreatic anticancer activity of a novel geranylgeranylated coumarin derivative
inferred← citeshttps://doi.org/10.1016/j.bpg.2005.10.003openalex-snapshot
Chemotherapy for advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1016/j.bpg.2016.08.001openalex-snapshot
Pancreatic cancer chemoradiotherapy
inferred← citeshttps://doi.org/10.1016/j.canrad.2010.10.001openalex-snapshot
Cancer du pancréas localement évolué non resécable : chimioradiothérapie d’induction suivie de chimiothérapie par gemcitabine contre chimiothérapie exclusive par gemcitabine : résultats définitifs de l’étude de phase III 2000–2001de la FFCD et de la SFRO
inferred← citeshttps://doi.org/10.1016/j.canrad.2018.06.005openalex-snapshot
Quelle place pour la radiothérapie dans la prise en charge des cancers du pancréas localisés ?
inferred← citeshttps://doi.org/10.1016/j.canrad.2020.06.010openalex-snapshot
Les essais cliniques en radiothérapie qui ont changé les pratiques 2010–2020
inferred← citeshttps://doi.org/10.1016/j.canrad.2020.08.047openalex-snapshot
Radiothérapie stéréotaxique dans le cancer du pancréas localement avancé : revue de la littérature
inferred← citeshttps://doi.org/10.1016/j.canrad.2025.104676openalex-snapshot
Hypofractionated radiotherapy for pancreatic cancer: What role in 2025?
inferred← citeshttps://doi.org/10.1016/j.clon.2008.02.003openalex-snapshot
Pancreatic Cancer within a UK Cancer Network with Special Emphasis on Locally Advanced Non-metastatic Pancreatic Cancer
inferred← citeshttps://doi.org/10.1016/j.clon.2009.09.024openalex-snapshot
Induction Chemotherapy Followed by Chemoradiation in Locally Advanced Pancreatic Cancer: an Effective and Well-tolerated Treatment
inferred← citeshttps://doi.org/10.1016/j.clon.2010.02.004openalex-snapshot
Radiotherapy in the Management of Unresectable Locally Advanced Pancreatic Cancer: a Survey of the Current UK Practice of Clinical Oncologists
inferred← citeshttps://doi.org/10.1016/j.clon.2010.03.005openalex-snapshot
Chemotherapy Followed by Chemoradiotherapy for Locally Advanced Non-metastatic Pancreatic Cancer — A New Paradigm?
inferred← citeshttps://doi.org/10.1016/j.clon.2010.05.007openalex-snapshot
Chemoradiotherapy with or without Induction Chemotherapy for Locally Advanced Pancreatic Cancer: a UK Multi-institutional Experience
inferred← citeshttps://doi.org/10.1016/j.clon.2014.01.003openalex-snapshot
Induction Gemcitabine Plus Concurrent Gemcitabine and Radiotherapy for Locally Advanced Unresectable or Resected Pancreatic Cancer
inferred← citeshttps://doi.org/10.1016/j.clon.2014.06.002openalex-snapshot
Locally Advanced Pancreatic Cancer: The Role of Definitive Chemoradiotherapy
inferred← citeshttps://doi.org/10.1016/j.clon.2026.104204openalex-snapshot
Proton Radiotherapy with Induction Chemotherapy for Locally Advanced Pancreatic Cancer: A Retrospective Analysis of Treatment Strategy and Outcomes
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2008.01.009openalex-snapshot
Pancreatic cancer: Progress in cancer therapy
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2008.09.016openalex-snapshot
Concomitant chemo-radiotherapy in clinical trials: To promote step by step rational development
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2015.11.016openalex-snapshot
Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2016.05.003openalex-snapshot
Hypofractionated radiotherapy in pancreatic cancer: Lessons from the past in the era of stereotactic body radiation therapy
inferred← citeshttps://doi.org/10.1016/j.ctro.2024.100778openalex-snapshot
Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocarcinoma
inferred← citeshttps://doi.org/10.1016/j.ctrv.2015.07.001openalex-snapshot
Molecular landscape of prostate cancer: Implications for current clinical trials
inferred← citeshttps://doi.org/10.1016/j.ctrv.2021.102208openalex-snapshot
European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Pancreatic Cancer
inferred← citeshttps://doi.org/10.1016/j.currproblcancer.2013.10.008openalex-snapshot
Radiosensitizers in pancreatic cancer—Preclinical and clinical exploits with molecularly targeted agents
inferred← citeshttps://doi.org/10.1016/j.currproblcancer.2017.10.006openalex-snapshot
Locally advanced pancreatic cancer: An emerging entity
inferred← citeshttps://doi.org/10.1016/j.cytogfr.2012.06.006openalex-snapshot
Targeted destruction of the orchestration of the pancreatic stroma and tumor cells in pancreatic cancer cases: Molecular basis for therapeutic implications
inferred← citeshttps://doi.org/10.1016/j.disamonth.2013.08.001openalex-snapshot
Pancreatic cancer: A comprehensive review and update
inferred← citeshttps://doi.org/10.1016/j.dld.2014.06.006openalex-snapshot
Radiation plus docetaxel and cisplatin in locally advanced pancreatic carcinoma: A non-comparative randomized phase II trial
inferred← citeshttps://doi.org/10.1016/j.dld.2018.08.008openalex-snapshot
Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC)
inferred← citeshttps://doi.org/10.1016/j.ejca.2012.07.017openalex-snapshot
Characteristics, therapy and outcome in an unselected and prospectively registered cohort of pancreatic cancer patients
inferred← citeshttps://doi.org/10.1016/j.ejca.2015.12.026openalex-snapshot
Current standards and new innovative approaches for treatment of pancreatic cancer
inferred← citeshttps://doi.org/10.1016/j.ejca.2024.114236openalex-snapshot
Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trial
inferred← citeshttps://doi.org/10.1016/j.ejmp.2015.12.009openalex-snapshot
Spot-scanned pancreatic stereotactic body proton therapy: A dosimetric feasibility and robustness study
inferred← citeshttps://doi.org/10.1016/j.ejso.2016.01.024openalex-snapshot
Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy
inferred← citeshttps://doi.org/10.1016/j.ejso.2018.07.047openalex-snapshot
Irreversible Electroporation in pancreatic ductal adenocarcinoma: Is there a role in conjunction with conventional treatment?
inferred← citeshttps://doi.org/10.1016/j.gendis.2015.01.002openalex-snapshot
Pancreatic cancer stromal biology and therapy
inferred← citeshttps://doi.org/10.1016/j.gie.2011.10.007openalex-snapshot
EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study
inferred← citeshttps://doi.org/10.1016/j.gie.2012.07.006openalex-snapshot
Comparative analysis of traditional and coiled fiducials implanted during EUS for pancreatic cancer patients receiving stereotactic body radiation therapy
inferred← citeshttps://doi.org/10.1016/j.gie.2015.01.026openalex-snapshot
Survival and clinical outcome after endoscopic duodenal stent placement for malignant gastric outlet obstruction: comparison of pancreatic cancer and nonpancreatic cancer
inferred← citeshttps://doi.org/10.1016/j.gtc.2011.12.004openalex-snapshot
Pancreatic Cancer: Medical Management (Novel Chemotherapeutics)
inferred← citeshttps://doi.org/10.1016/j.hoc.2015.04.005openalex-snapshot
Treatment Approaches to Locally Advanced Pancreatic Adenocarcinoma
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2008.07.015openalex-snapshot
Multicriteria Optimization in Intensity-Modulated Radiation Therapy Treatment Planning for Locally Advanced Cancer of the Pancreatic Head
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2009.02.013openalex-snapshot
External Beam Radiotherapy Plus 24-Hour Continuous Infusion of Gemcitabine in Unresectable Pancreatic Carcinoma: Long-Term Results of a Phase II Study
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2009.05.063openalex-snapshot
Patterns of Radiotherapy Practice for Pancreatic Cancer in Japan: Results of the Japanese Radiation Oncology Study Group (JROSG) Survey
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2009.08.046openalex-snapshot
Stereotactic Body Radiotherapy and Gemcitabine for Locally Advanced Pancreatic Cancer
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2010.10.034openalex-snapshot
Induction Chemotherapy With Gemcitabine, Oxaliplatin, and 5-Fluorouracil/Leucovorin Followed by Concomitant Chemoradiotherapy in Patients With Locally Advanced Pancreatic Cancer: A Taiwan Cooperative Oncology Group Phase II Study
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2011.02.063openalex-snapshot
Pretreatment Carbohydrate Antigen 19-9 Level Indicates Tumor Response, Early Distant Metastasis, Overall Survival, and Therapeutic Selection in Localized and Unresectable Pancreatic Cancer
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2011.04.045openalex-snapshot
Induction Gemcitabine and Stereotactic Body Radiotherapy for Locally Advanced Nonmetastatic Pancreas Cancer
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2011.08.008openalex-snapshot
Treatment of Locally Advanced Pancreatic Cancer: The Role of Radiation Therapy
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2011.09.008openalex-snapshot
Prognostic Factors for Survival and Resection in Patients With Initial Nonresectable Locally Advanced Pancreatic Cancer Treated With Chemoradiotherapy
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2011.11.050openalex-snapshot
Radiotherapy Technical Considerations in the Management of Locally Advanced Pancreatic Cancer: American-French Consensus Recommendations
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2012.03.003openalex-snapshot
Impact of Gemcitabine Chemotherapy and 3-Dimensional Conformal Radiation Therapy/5-Fluorouracil on Quality of Life of Patients Managed for Pancreatic Cancer
showing the first 200 of 514 · page through all 514
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.